In colon cancer, it has been suggested that EGR1 serve as a tumor suppressor [36,37] that is downregulated or lost as a consequence of APC mutation and the subsequent nuclear accumulation of β-catenin [37,38,39]. The gene discussed is EGR1; the disease is malignant colon neoplasm.